| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.599 | 0.005 | 0.74 | Alpha adrenoreceptor antagonist | 0.32 0.014 DBMET03294 0.297 0.016 DBMET03295 0.463 0.007 DBMET03298 0.181 0.03 DBMET03299 0.168 0.033 DBMET03300 0.74 0.004 DBMET03302 0.114 0.049 DBMET03297 | DBMET03302 | |
| 0.594 | 0.003 | 0.609 | Alpha 1d adrenoreceptor antagonist | 0.251 0.007 DBMET03294 0.362 0.004 DBMET03295 0.374 0.004 DBMET03298 0.165 0.013 DBMET03299 0.164 0.013 DBMET03300 0.609 0.003 DBMET03302 0.108 0.021 DBMET03297 | DBMET03302 | |
| 0.594 | 0.003 | 0.595 | Alpha 1b adrenoreceptor antagonist | 0.26 0.009 DBMET03294 0.363 0.005 DBMET03295 0.409 0.005 DBMET03298 0.176 0.018 DBMET03299 0.182 0.017 DBMET03300 0.595 0.003 DBMET03302 0.112 0.031 DBMET03297 | DBMET03302 | |
| 0.591 | 0.004 | 0.591 | Alpha 1 adrenoreceptor antagonist | 0.326 0.009 DBMET03294 0.315 0.01 DBMET03295 0.38 0.007 DBMET03298 0.167 0.026 DBMET03299 0.106 0.041 DBMET03300 0.578 0.004 DBMET03302 0.137 0.032 DBMET03297 | ||
| 0.575 | 0.024 | 0.672 | Antiobesity | 0.54 0.029 DBMET03293 0.571 0.024 DBMET03294 0.511 0.035 DBMET03295 0.626 0.018 DBMET03298 0.351 0.087 DBMET03299 0.54 0.029 DBMET03300 0.569 0.025 DBMET03301 0.672 0.013 DBMET03302 0.487 0.04 DBMET03296 0.509 0.035 DBMET03297 | DBMET03302 | |
| 0.503 | 0.004 | 0.503 | Alpha 1a adrenoreceptor antagonist | 0.169 0.021 DBMET03294 0.21 0.015 DBMET03295 0.279 0.01 DBMET03298 0.132 0.027 DBMET03299 0.08 0.045 DBMET03300 0.484 0.005 DBMET03302 | ||
| 0.453 | 0.006 | 0.597 | Antiadrenergic | 0.19 0.026 DBMET03293 0.362 0.01 DBMET03294 0.336 0.011 DBMET03295 0.443 0.007 DBMET03298 0.356 0.01 DBMET03299 0.258 0.017 DBMET03300 0.197 0.025 DBMET03301 0.597 0.005 DBMET03302 0.127 0.043 DBMET03296 0.254 0.017 DBMET03297 | DBMET03302 | |
| 0.447 | 0.007 | 0.592 | Adrenaline antagonist | 0.185 0.026 DBMET03293 0.356 0.01 DBMET03294 0.333 0.011 DBMET03295 0.439 0.007 DBMET03298 0.351 0.01 DBMET03299 0.253 0.017 DBMET03300 0.193 0.025 DBMET03301 0.592 0.005 DBMET03302 0.124 0.042 DBMET03296 0.25 0.017 DBMET03297 | DBMET03302 | |
| 0.459 | 0.064 | 0.712 | Cyclophilin D inhibitor | 0.679 0.016 DBMET03293 0.536 0.041 DBMET03294 0.431 0.075 DBMET03295 0.422 0.079 DBMET03298 0.469 0.06 DBMET03299 0.434 0.074 DBMET03300 0.712 0.013 DBMET03301 0.479 0.057 DBMET03302 0.665 0.018 DBMET03296 0.509 0.047 DBMET03297 | DBMET03301 | |
| 0.405 | 0.028 | 0.52 | Cardiotonic | 0.297 0.057 DBMET03293 0.396 0.03 DBMET03294 0.334 0.044 DBMET03295 0.404 0.028 DBMET03298 0.52 0.014 DBMET03299 0.273 0.068 DBMET03300 0.351 0.039 DBMET03301 0.494 0.016 DBMET03302 0.244 0.087 DBMET03296 0.328 0.046 DBMET03297 | DBMET03299 | |
| 0.404 | 0.045 | 0.671 | 5 Hydroxytryptamine release stimulant | 0.264 0.083 DBMET03293 0.363 0.054 DBMET03294 0.168 0.155 DBMET03295 0.671 0.009 DBMET03298 0.603 0.014 DBMET03299 0.601 0.014 DBMET03301 | DBMET03298 | |
| 0.356 | 0.01 | 0.356 | Nav1.2 sodium channel blocker | 0.216 0.029 DBMET03294 0.276 0.018 DBMET03295 0.21 0.031 DBMET03298 0.263 0.02 DBMET03299 0.245 0.023 DBMET03300 0.189 0.039 DBMET03302 0.159 0.052 DBMET03297 | ||
| 0.365 | 0.029 | 0.433 | Psychostimulant | 0.23 0.066 DBMET03293 0.389 0.024 DBMET03294 0.366 0.028 DBMET03295 0.433 0.018 DBMET03298 0.242 0.062 DBMET03299 0.146 0.12 DBMET03301 0.404 0.022 DBMET03302 0.232 0.065 DBMET03296 0.391 0.024 DBMET03297 | DBMET03298 | |
| 0.339 | 0.018 | 0.478 | Ca(v)3.3 blocker | 0.264 0.08 DBMET03293 0.329 0.023 DBMET03294 0.339 0.018 DBMET03295 0.345 0.016 DBMET03298 0.478 0.003 DBMET03299 0.307 0.037 DBMET03300 0.269 0.074 DBMET03301 0.312 0.033 DBMET03302 0.264 0.08 DBMET03296 0.329 0.023 DBMET03297 | DBMET03299 | |
| 0.291 | 0.013 | 0.494 | Anesthetic local | 0.204 0.031 DBMET03294 0.196 0.033 DBMET03295 0.215 0.028 DBMET03298 0.284 0.014 DBMET03299 0.494 0.004 DBMET03302 0.115 0.071 DBMET03297 | DBMET03302 | |
| 0.327 | 0.068 | 0.627 | Vasodilator, coronary | 0.554 0.01 DBMET03293 0.267 0.118 DBMET03294 0.265 0.12 DBMET03295 0.279 0.106 DBMET03298 0.361 0.05 DBMET03299 0.627 0.006 DBMET03301 0.383 0.041 DBMET03302 0.473 0.019 DBMET03296 | DBMET03301 | |
| 0.32 | 0.063 | 0.569 | Spasmolytic | 0.442 0.032 DBMET03293 0.297 0.071 DBMET03294 0.201 0.118 DBMET03295 0.303 0.069 DBMET03298 0.274 0.081 DBMET03299 0.41 0.038 DBMET03300 0.369 0.047 DBMET03301 0.569 0.016 DBMET03302 0.307 0.067 DBMET03296 0.187 0.131 DBMET03297 | DBMET03302 | |
| 0.248 | 0.07 | 0.394 | Vasodilator | 0.377 0.027 DBMET03293 0.262 0.063 DBMET03294 0.183 0.119 DBMET03295 0.276 0.057 DBMET03298 0.293 0.05 DBMET03299 0.239 0.075 DBMET03300 0.365 0.03 DBMET03301 0.394 0.024 DBMET03302 0.326 0.04 DBMET03296 0.2 0.105 DBMET03297 | DBMET03302 | |
| 0.196 | 0.026 | 0.265 | Nav1.3 sodium channel blocker | 0.125 0.069 DBMET03294 0.24 0.015 DBMET03295 0.171 0.036 DBMET03298 0.265 0.012 DBMET03299 0.133 0.061 DBMET03302 0.156 0.044 DBMET03297 | DBMET03299 | |
| 0.167 | 0.026 | 0.279 | Bronchodilator | 0.1 0.065 DBMET03293 0.149 0.032 DBMET03294 0.169 0.025 DBMET03295 0.169 0.025 DBMET03298 0.106 0.057 DBMET03300 0.122 0.043 DBMET03301 0.279 0.01 DBMET03302 0.101 0.063 DBMET03296 0.152 0.031 DBMET03297 | DBMET03302 | |
| 0.184 | 0.045 | 0.243 | Insulin secretagoues | 0.243 0.021 DBMET03293 0.215 0.029 DBMET03294 0.118 0.114 DBMET03295 0.119 0.113 DBMET03299 0.229 0.024 DBMET03301 0.146 0.078 DBMET03302 0.189 0.042 DBMET03296 0.154 0.07 DBMET03297 | DBMET03293 | |
| 0.148 | 0.015 | 0.241 | Adrenaline agonist | 0.123 0.024 DBMET03294 0.107 0.032 DBMET03295 0.208 0.006 DBMET03298 0.077 0.061 DBMET03299 0.241 0.005 DBMET03302 0.086 0.051 DBMET03297 | DBMET03302 | |
| 0.178 | 0.066 | 0.178 | MAP kinase kinase 5 inhibitor | 0.164 0.101 DBMET03294 0.168 0.091 DBMET03295 0.162 0.107 DBMET03298 0.175 0.074 DBMET03302 0.154 0.138 DBMET03297 | ||
| 0.254 | 0.144 | 0.371 | Toll-Like receptor agonist | 0.208 0.192 DBMET03293 0.303 0.109 DBMET03294 0.302 0.11 DBMET03295 0.209 0.191 DBMET03298 0.371 0.072 DBMET03302 0.242 0.156 DBMET03296 0.348 0.083 DBMET03297 | DBMET03302 | |
| 0.244 | 0.135 | 0.302 | Sodium/bile acid cotransporter inhibitor | 0.215 0.168 DBMET03293 0.302 0.077 DBMET03294 0.232 0.148 DBMET03295 0.216 0.166 DBMET03298 0.223 0.158 DBMET03300 0.249 0.129 DBMET03302 0.206 0.18 DBMET03296 0.295 0.084 DBMET03297 | DBMET03294 | |
| 0.118 | 0.01 | 0.161 | Beta 3 adrenoreceptor antagonist | 0.085 0.02 DBMET03294 0.108 0.013 DBMET03295 0.144 0.006 DBMET03298 0.082 0.022 DBMET03299 0.161 0.005 DBMET03302 0.078 0.025 DBMET03297 | DBMET03302 | |
| 0.143 | 0.036 | 0.201 | Nav1.1 sodium channel blocker | 0.119 0.049 DBMET03294 0.106 0.059 DBMET03295 0.113 0.053 DBMET03298 0.201 0.019 DBMET03299 0.096 0.071 DBMET03302 0.089 0.082 DBMET03297 | DBMET03299 | |
| 0.155 | 0.049 | 0.339 | Nav1.6 sodium channel blocker | 0.119 0.098 DBMET03294 0.136 0.072 DBMET03295 0.165 0.039 DBMET03298 0.339 0.005 DBMET03299 | DBMET03299 | |
| 0.249 | 0.148 | 0.367 | Toll-Like receptor 7 agonist | 0.299 0.111 DBMET03294 0.295 0.113 DBMET03295 0.207 0.193 DBMET03298 0.367 0.074 DBMET03302 0.219 0.179 DBMET03296 0.345 0.084 DBMET03297 | DBMET03302 | |
| 0.235 | 0.138 | 0.665 | Antithrombotic | 0.665 0.01 DBMET03293 0.391 0.052 DBMET03294 0.194 0.185 DBMET03298 0.226 0.147 DBMET03299 0.459 0.036 DBMET03300 0.623 0.014 DBMET03301 0.346 0.066 DBMET03302 0.619 0.014 DBMET03296 0.323 0.075 DBMET03297 | DBMET03293 | |
| 0.107 | 0.014 | 0.16 | Beta adrenoreceptor antagonist | 0.095 0.019 DBMET03294 0.094 0.019 DBMET03295 0.15 0.006 DBMET03298 0.105 0.015 DBMET03299 0.16 0.005 DBMET03302 0.082 0.026 DBMET03297 | DBMET03302 | |
| 0.119 | 0.031 | 0.313 | ABCA1 expression enhancer | 0.087 0.072 DBMET03293 0.125 0.027 DBMET03294 0.121 0.03 DBMET03295 0.12 0.031 DBMET03298 0.313 0.005 DBMET03299 0.093 0.061 DBMET03300 0.092 0.062 DBMET03302 0.088 0.07 DBMET03296 0.126 0.027 DBMET03297 | DBMET03299 | |
| 0.259 | 0.175 | 0.467 | Analgesic | 0.267 0.168 DBMET03294 0.262 0.172 DBMET03298 0.467 0.06 DBMET03299 0.274 0.162 DBMET03302 | DBMET03299 | |
| 0.144 | 0.064 | 0.238 | Calcium channel blocker | 0.133 0.074 DBMET03294 0.113 0.095 DBMET03298 0.238 0.019 DBMET03299 0.11 0.1 DBMET03302 | DBMET03299 | |
| 0.106 | 0.032 | 0.147 | 5 Hydroxytryptamine agonist | 0.063 0.052 DBMET03294 0.147 0.022 DBMET03298 0.063 0.052 DBMET03299 0.075 0.044 DBMET03302 | DBMET03298 | |
| 0.187 | 0.117 | 0.345 | Peptidyltransferase inhibitor | 0.299 0.025 DBMET03293 0.18 0.129 DBMET03294 0.189 0.114 DBMET03295 0.24 0.058 DBMET03299 0.264 0.041 DBMET03301 0.345 0.013 DBMET03302 0.299 0.025 DBMET03296 0.18 0.128 DBMET03297 | DBMET03302 | |
| 0.085 | 0.015 | 0.123 | Beta 1 adrenoreceptor antagonist | 0.074 0.023 DBMET03294 0.074 0.023 DBMET03295 0.12 0.007 DBMET03298 0.072 0.024 DBMET03299 0.123 0.007 DBMET03302 0.062 0.034 DBMET03297 | DBMET03302 | |
| 0.142 | 0.073 | 0.155 | MAP3K9 inhibitor | 0.136 0.084 DBMET03295 0.155 0.052 DBMET03302 | DBMET03302 | |
| 0.178 | 0.111 | 0.278 | Hypolipemic | 0.278 0.056 DBMET03293 0.231 0.077 DBMET03294 0.191 0.101 DBMET03299 0.246 0.069 DBMET03301 0.224 0.08 DBMET03302 0.243 0.071 DBMET03296 0.189 0.103 DBMET03297 | DBMET03293 | |
| 0.072 | 0.008 | 0.12 | Sphingosine 1-phosphate receptor 1 agonist | 0.12 0.004 DBMET03294 0.061 0.012 DBMET03295 0.046 0.024 DBMET03298 0.077 0.006 DBMET03299 0.064 0.011 DBMET03302 0.092 0.005 DBMET03297 | DBMET03294 | |
| 0.071 | 0.017 | 0.175 | 5 Hydroxytryptamine 1B agonist | 0.063 0.023 DBMET03294 0.06 0.027 DBMET03295 0.089 0.009 DBMET03298 0.175 0.004 DBMET03299 0.054 0.035 DBMET03300 0.06 0.026 DBMET03302 0.053 0.037 DBMET03297 | DBMET03299 | |
| 0.07 | 0.02 | 0.083 | Beta 2 adrenoreceptor agonist | 0.062 0.041 DBMET03294 0.06 0.051 DBMET03295 0.068 0.023 DBMET03298 0.062 0.041 DBMET03299 0.083 0.007 DBMET03302 | DBMET03302 | |
| 0.181 | 0.133 | 0.436 | Hypoglycemic | 0.423 0.024 DBMET03293 0.243 0.081 DBMET03294 0.298 0.053 DBMET03299 0.436 0.022 DBMET03301 0.22 0.096 DBMET03302 0.395 0.028 DBMET03296 0.209 0.104 DBMET03297 | DBMET03301 | |
| 0.062 | 0.015 | 0.112 | Sphingosine 1-phosphate receptor agonist | 0.112 0.005 DBMET03294 0.054 0.021 DBMET03295 0.08 0.009 DBMET03299 0.051 0.024 DBMET03302 0.096 0.006 DBMET03297 | DBMET03294 | |
| 0.163 | 0.117 | 0.186 | HERG channel blocker | 0.186 0.099 DBMET03299 | DBMET03299 | |
| 0.08 | 0.037 | 0.08 | Dopamine agonist | 0.072 0.042 DBMET03302 | ||
| 0.085 | 0.044 | 0.127 | 5 Hydroxytryptamine 1 antagonist | 0.127 0.028 DBMET03298 0.106 0.035 DBMET03302 | DBMET03298 | |
| 0.052 | 0.014 | 0.072 | Beta adrenoreceptor agonist | 0.049 0.02 DBMET03294 0.047 0.024 DBMET03295 0.061 0.008 DBMET03298 0.072 0.005 DBMET03302 0.045 0.033 DBMET03297 | DBMET03302 | |
| 0.257 | 0.219 | 0.45 | 5 Hydroxytryptamine release inhibitor | 0.255 0.221 DBMET03293 0.283 0.185 DBMET03295 0.304 0.16 DBMET03298 0.45 0.051 DBMET03299 0.281 0.187 DBMET03296 | DBMET03299 | |
| 0.085 | 0.048 | 0.19 | Ca(v)3.1 blocker | 0.082 0.054 DBMET03294 0.08 0.061 DBMET03295 0.086 0.043 DBMET03298 0.19 0.004 DBMET03299 0.077 0.069 DBMET03297 | DBMET03299 | |
| 0.106 | 0.07 | 0.233 | Alpha 2b adrenoreceptor antagonist | 0.233 0.017 DBMET03298 0.19 0.026 DBMET03299 0.137 0.046 DBMET03302 | DBMET03298 | |
| 0.132 | 0.096 | 0.197 | Sphingosine 1-phosphate receptor 5 antagonist | 0.136 0.087 DBMET03294 0.197 0.013 DBMET03299 | DBMET03299 | |
| 0.06 | 0.024 | 0.1 | Beta 2 adrenoreceptor antagonist | 0.058 0.026 DBMET03294 0.051 0.035 DBMET03295 0.1 0.008 DBMET03298 0.063 0.022 DBMET03299 0.087 0.01 DBMET03302 0.05 0.037 DBMET03297 | DBMET03298 | |
| 0.061 | 0.029 | 0.074 | Myc inhibitor | 0.053 0.041 DBMET03294 0.052 0.042 DBMET03295 0.074 0.016 DBMET03298 0.056 0.035 DBMET03302 | DBMET03298 | |
| 0.195 | 0.164 | 0.195 | Nootropic | 0.187 0.177 DBMET03302 | ||
| 0.062 | 0.037 | 0.062 | Cathepsin L inhibitor | 0.055 0.044 DBMET03298 0.056 0.043 DBMET03299 | ||
| 0.127 | 0.102 | 0.13 | Thiol protease inhibitor | 0.13 0.097 DBMET03295 | DBMET03295 | |
| 0.101 | 0.082 | 0.16 | Calcium channel (voltage-sensitive) blocker | 0.16 0.029 DBMET03299 | DBMET03299 | |
| 0.085 | 0.067 | 0.127 | Aminoacyl-tRNA synthetase inhibitor | 0.099 0.046 DBMET03295 0.119 0.03 DBMET03298 0.127 0.027 DBMET03299 0.09 0.058 DBMET03301 0.086 0.066 DBMET03296 0.092 0.056 DBMET03297 | DBMET03299 | |
| 0.065 | 0.049 | 0.1 | 5 Hydroxytryptamine 1A antagonist | 0.1 0.032 DBMET03298 0.096 0.034 DBMET03302 | DBMET03298 | |
| 0.054 | 0.04 | 0.085 | Epithelial sodium channel blocker | 0.058 0.031 DBMET03298 0.085 0.01 DBMET03299 | DBMET03299 | |
| 0.039 | 0.028 | 0.04 | Cathepsin L1 inhibitor | 0.04 0.027 DBMET03298 0.039 0.027 DBMET03299 | DBMET03298 | |
| 0.089 | 0.08 | 0.166 | Gastric antisecretory | 0.166 0.02 DBMET03299 0.089 0.08 DBMET03302 | DBMET03299 | |
| 0.147 | 0.139 | 0.151 | Potassium channel (Voltage-sensitive) blocker | 0.151 0.136 DBMET03299 | DBMET03299 | |
| 0.096 | 0.088 | 0.127 | 5 Hydroxytryptamine 2B antagonist | 0.127 0.054 DBMET03298 | DBMET03298 | |
| 0.093 | 0.086 | 0.121 | 5 Hydroxytryptamine antagonist | 0.121 0.064 DBMET03298 | DBMET03298 | |
| 0.118 | 0.113 | 0.216 | Thrombolytic | 0.208 0.048 DBMET03293 0.162 0.073 DBMET03294 0.129 0.101 DBMET03295 0.188 0.058 DBMET03299 0.144 0.086 DBMET03300 0.181 0.061 DBMET03301 0.216 0.045 DBMET03296 0.173 0.066 DBMET03297 | DBMET03296 | |
| 0.092 | 0.092 | 0.099 | Factor V inhibitor | 0.099 0.07 DBMET03294 0.095 0.083 DBMET03298 0.098 0.075 DBMET03297 | DBMET03294 | |
| 0.026 | 0.03 | 0.044 | Sphingosine 1-phosphate receptor 3 agonist | 0.044 0.019 DBMET03294 0.039 0.022 DBMET03299 0.038 0.022 DBMET03297 | DBMET03294 | |
| 0.041 | 0.05 | 0.109 | 5 Hydroxytryptamine 2 agonist | 0.109 0.008 DBMET03298 0.094 0.01 DBMET03299 | DBMET03298 | |
| 0.117 | 0.127 | 0.165 | Growth hormone agonist | 0.165 0.076 DBMET03294 0.128 0.11 DBMET03297 | DBMET03294 | |
| 0.112 | 0.123 | 0.306 | Anticoagulant | 0.208 0.05 DBMET03293 0.173 0.064 DBMET03294 0.137 0.093 DBMET03298 0.306 0.027 DBMET03300 0.153 0.077 DBMET03301 0.194 0.055 DBMET03296 0.158 0.074 DBMET03297 | DBMET03300 | |
| 0.112 | 0.128 | 0.253 | Phospholipase A2 inhibitor | 0.182 0.053 DBMET03294 0.163 0.064 DBMET03295 0.208 0.038 DBMET03299 0.164 0.063 DBMET03300 0.165 0.062 DBMET03296 0.253 0.022 DBMET03297 | DBMET03297 | |
| 0.064 | 0.083 | 0.101 | 5 Hydroxytryptamine 2C antagonist | 0.101 0.045 DBMET03298 | DBMET03298 | |
| 0.04 | 0.061 | 0.05 | Cathepsin D inhibitor | 0.05 0.042 DBMET03300 | DBMET03300 | |
| 0.005 | 0.027 | 0.013 | Beta 3 adrenoreceptor agonist | 0.013 0.007 DBMET03298 | DBMET03298 | |
| 0.037 | 0.066 | 0.05 | Human rhinovirus A protease inhibitor | 0.05 0.043 DBMET03298 | DBMET03298 | |
| 0.097 | 0.126 | 0.141 | Histone deacetylase SIRT1 inhibitor | 0.108 0.107 DBMET03295 0.141 0.07 DBMET03298 0.118 0.093 DBMET03297 | DBMET03298 | |
| 0.186 | 0.215 | 0.422 | Interleukin 2 agonist | 0.38 0.034 DBMET03293 0.208 0.176 DBMET03294 0.229 0.144 DBMET03295 0.422 0.021 DBMET03301 0.4 0.027 DBMET03296 0.247 0.121 DBMET03297 | DBMET03301 | |
| 0.123 | 0.165 | 0.181 | Potassium channel blocker | 0.181 0.106 DBMET03298 | DBMET03298 | |
| 0.027 | 0.069 | 0.039 | Calcium-independent phospholipase A2 inhibitor | 0.039 0.012 DBMET03299 | DBMET03299 | |
| 0.167 | 0.208 | 0.28 | Tyrosine 3 hydroxylase inhibitor | 0.236 0.082 DBMET03294 0.198 0.139 DBMET03298 0.28 0.044 DBMET03299 | DBMET03299 | |
| 0.045 | 0.087 | 0.14 | Ca(v)3.2 blocker | 0.14 0.005 DBMET03299 | DBMET03299 | |
| 0.014 | 0.056 | 0.039 | Protein 30S ribosomal subunit inhibitor | 0.026 0.015 DBMET03293 0.039 0.01 DBMET03301 0.025 0.016 DBMET03296 | DBMET03301 | |
| 0.05 | 0.094 | 0.078 | Thrombin inhibitor | 0.067 0.059 DBMET03298 0.078 0.044 DBMET03300 | DBMET03300 | |
| 0.03 | 0.076 | 0.072 | Poly(ADP-ribose) polymerase inhibitor | 0.072 0.012 DBMET03298 | DBMET03298 | |
| 0.12 | 0.166 | 0.146 | P-glycoprotein inhibitor | 0.146 0.123 DBMET03299 | DBMET03299 | |
| 0.041 | 0.087 | 0.087 | Sphingosine 1-phosphate receptor 5 agonist | 0.087 0.011 DBMET03294 0.08 0.013 DBMET03297 | DBMET03294 | |
| 0.164 | 0.211 | 0.405 | Immunomodulator | 0.381 0.05 DBMET03293 0.186 0.18 DBMET03295 0.219 0.142 DBMET03300 0.405 0.042 DBMET03301 0.4 0.044 DBMET03296 | DBMET03301 | |
| 0.05 | 0.1 | 0.121 | Calcium channel L-type blocker | 0.121 0.016 DBMET03299 | DBMET03299 | |
| 0.117 | 0.169 | 0.343 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.207 0.072 DBMET03295 0.169 0.097 DBMET03298 0.343 0.03 DBMET03299 0.148 0.113 DBMET03297 | DBMET03299 | |
| 0.022 | 0.077 | 0.079 | Cholecystokinin B agonist | 0.079 0.008 DBMET03300 | DBMET03300 | |
| 0.144 | 0.199 | 0.185 | ErbB-1 antagonist | 0.185 0.108 DBMET03299 | DBMET03299 | |
| 0.012 | 0.069 | 0.021 | Beta 1 adrenoreceptor agonist | 0.021 0.02 DBMET03298 | DBMET03298 | |
| 0.031 | 0.089 | 0.143 | H+/K+-transporting ATPase inhibitor | 0.143 0.005 DBMET03299 | DBMET03299 | |
| 0.084 | 0.142 | 0.17 | Lipid peroxidase inhibitor | 0.17 0.056 DBMET03293 0.162 0.06 DBMET03301 0.122 0.091 DBMET03296 | DBMET03293 | |
| 0.007 | 0.072 | 0.071 | Cholecystokinin agonist | 0.071 0.005 DBMET03300 | DBMET03300 | |
| 0.114 | 0.18 | 0.194 | Anticonvulsant | 0.159 0.118 DBMET03294 0.148 0.132 DBMET03298 0.194 0.087 DBMET03299 | DBMET03299 | |
| 0.016 | 0.082 | 0.033 | Retinoid X gamma receptor antagonist | 0.033 0.009 DBMET03299 | DBMET03299 | |
| 0.02 | 0.087 | 0.066 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.066 0.011 DBMET03298 | DBMET03298 | |
| 0.044 | 0.111 | 0.196 | Nav1.8 sodium channel blocker | 0.196 0.008 DBMET03299 | DBMET03299 | |
| 0.015 | 0.082 | 0.046 | 5 Hydroxytryptamine 2C agonist | 0.046 0.03 DBMET03298 | DBMET03298 | |
| 0.135 | 0.202 | 0.169 | Calpain inhibitor | 0.169 0.15 DBMET03299 | DBMET03299 | |
| 0.018 | 0.086 | 0.077 | Urokinase inhibitor | 0.077 0.022 DBMET03299 | DBMET03299 | |
| 0.202 | 0.27 | 0.385 | Calcium channel L-type activator | 0.253 0.202 DBMET03298 0.253 0.202 DBMET03299 0.385 0.091 DBMET03302 | DBMET03302 | |
| 0.007 | 0.077 | 0.063 | Cholecystokinin A agonist | 0.063 0.005 DBMET03300 | DBMET03300 | |
| 0.037 | 0.108 | 0.101 | 5 Hydroxytryptamine 1F antagonist | 0.101 0.031 DBMET03298 | DBMET03298 | |
| 0.013 | 0.086 | 0.034 | Gonadotropin-releasing hormone receptor antagonist | 0.034 0.024 DBMET03298 | DBMET03298 | |
| 0.068 | 0.143 | 0.097 | Acetylcholine muscarinic antagonist | 0.097 0.094 DBMET03302 | DBMET03302 | |
| 0.068 | 0.143 | 0.099 | Histone deacetylase class III inhibitor | 0.099 0.091 DBMET03297 | DBMET03297 | |
| 0.035 | 0.111 | 0.071 | 5 Hydroxytryptamine 1B antagonist | 0.071 0.04 DBMET03298 | DBMET03298 | |
| 0.062 | 0.141 | 0.119 | DNA intercalator | 0.094 0.08 DBMET03295 0.09 0.085 DBMET03301 0.119 0.058 DBMET03296 | DBMET03296 | |
| 0.093 | 0.173 | 0.279 | Protein kinase (CK1) gamma 3 inhibitor | 0.134 0.108 DBMET03295 0.124 0.121 DBMET03298 0.279 0.021 DBMET03299 | DBMET03299 | |
| 0.033 | 0.115 | 0.057 | Sphingosine kinase 2 inhibitor | 0.057 0.035 DBMET03299 | DBMET03299 | |
| 0.154 | 0.236 | 0.477 | Vasodilator, peripheral | 0.305 0.094 DBMET03293 0.243 0.132 DBMET03294 0.342 0.077 DBMET03298 0.343 0.077 DBMET03299 0.477 0.033 DBMET03301 0.46 0.038 DBMET03302 | DBMET03301 | |
| 0.041 | 0.128 | 0.065 | Protein kinase B alpha inhibitor | 0.065 0.054 DBMET03299 | DBMET03299 | |
| 0.085 | 0.173 | 0.139 | Acetylcholine M1 receptor antagonist | 0.116 0.115 DBMET03299 0.139 0.085 DBMET03302 | DBMET03302 | |
| 0.024 | 0.113 | 0.041 | Neuraminidase (Influenza A) inhibitor | 0.041 0.04 DBMET03299 | DBMET03299 | |
| 0.044 | 0.135 | 0.078 | Secretase beta inhibitor | 0.078 0.039 DBMET03299 | DBMET03299 | |
| 0.092 | 0.184 | 0.163 | Vanilloid 1 agonist | 0.163 0.028 DBMET03299 0.12 0.087 DBMET03301 | DBMET03299 | |
| 0.028 | 0.121 | 0.055 | 5 Hydroxytryptamine 1D antagonist | 0.055 0.054 DBMET03298 | DBMET03298 | |
| 0.053 | 0.148 | 0.185 | Sphingomyelinase inhibitor | 0.185 0.013 DBMET03299 0.092 0.07 DBMET03301 0.127 0.036 DBMET03302 | DBMET03299 | |
| 0.028 | 0.124 | 0.144 | 5 Hydroxytryptamine 2A agonist | 0.094 0.017 DBMET03298 0.144 0.005 DBMET03299 | DBMET03299 | |
| 0.071 | 0.17 | 0.103 | Folate antagonist | 0.093 0.078 DBMET03294 0.103 0.059 DBMET03297 | DBMET03297 | |
| 0.102 | 0.201 | 0.242 | Insulin sensitizer | 0.184 0.09 DBMET03294 0.174 0.102 DBMET03295 0.154 0.128 DBMET03298 0.235 0.043 DBMET03299 0.159 0.121 DBMET03296 0.242 0.039 DBMET03297 | DBMET03297 | |
| 0.08 | 0.185 | 0.422 | Angiogenesis stimulant | 0.417 0.019 DBMET03293 0.226 0.081 DBMET03300 0.391 0.023 DBMET03301 0.422 0.018 DBMET03296 | DBMET03296 | |
| 0.048 | 0.154 | 0.106 | Check point kinase 2 inhibitor | 0.106 0.06 DBMET03298 | DBMET03298 | |
| 0.037 | 0.143 | 0.07 | Aminopeptidase I inhibitor | 0.07 0.053 DBMET03299 | DBMET03299 | |
| 0.09 | 0.197 | 0.182 | Sphingosine 1-phosphate receptor 2 antagonist | 0.182 0.014 DBMET03299 | DBMET03299 | |
| 0.058 | 0.166 | 0.115 | Nitric-oxide synthase inhibitor | 0.115 0.041 DBMET03299 | DBMET03299 | |
| 0.061 | 0.17 | 0.131 | Vanilloid agonist | 0.131 0.014 DBMET03299 | DBMET03299 | |
| 0.013 | 0.127 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.017 DBMET03299 0.023 0.022 DBMET03300 | DBMET03299 | |
| 0.09 | 0.207 | 0.245 | Hemostatic | 0.243 0.023 DBMET03293 0.128 0.099 DBMET03294 0.149 0.069 DBMET03298 0.211 0.029 DBMET03299 0.157 0.06 DBMET03300 0.184 0.04 DBMET03301 0.245 0.023 DBMET03296 0.129 0.098 DBMET03297 | DBMET03296 | |
| 0.145 | 0.262 | 0.384 | Immunosuppressant | 0.373 0.075 DBMET03293 0.368 0.077 DBMET03301 0.384 0.07 DBMET03296 | DBMET03296 | |
| 0.005 | 0.124 | 0.039 | Dopamine autoreceptor agonist | 0.039 0.01 DBMET03299 | DBMET03299 | |
| 0.131 | 0.254 | 0.183 | Gastrin inhibitor | 0.183 0.174 DBMET03294 | DBMET03294 | |
| 0.007 | 0.133 | 0.067 | Leukotriene A4 hydrolase inhibitor | 0.067 0.012 DBMET03299 | DBMET03299 | |
| 0.038 | 0.172 | 0.097 | Alpha 2 adrenoreceptor antagonist | 0.091 0.055 DBMET03298 0.097 0.05 DBMET03299 0.08 0.066 DBMET03302 | DBMET03299 | |
| 0.019 | 0.157 | 0.055 | Antibiotic Aminoglycoside-like | 0.045 0.016 DBMET03293 0.055 0.01 DBMET03301 0.044 0.017 DBMET03296 | DBMET03301 | |
| 0.005 | 0.147 | 0.072 | Glycine transporter 1 inhibitor | 0.072 0.009 DBMET03299 | DBMET03299 | |
| 0.022 | 0.167 | 0.266 | Selectin antagonist | 0.232 0.009 DBMET03293 0.094 0.03 DBMET03300 0.266 0.007 DBMET03301 0.246 0.008 DBMET03296 | DBMET03301 | |
| 0.01 | 0.159 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 DBMET03299 | DBMET03299 | |
| 0.025 | 0.175 | 0.068 | Alpha adrenoreceptor agonist | 0.068 0.048 DBMET03298 0.068 0.047 DBMET03302 | DBMET03302 | |
| 0.085 | 0.237 | 0.41 | Interleukin agonist | 0.284 0.057 DBMET03293 0.201 0.12 DBMET03299 0.41 0.017 DBMET03301 0.292 0.052 DBMET03296 | DBMET03301 | |
| 0.039 | 0.197 | 0.248 | MAO inhibitor | 0.248 0.028 DBMET03299 | DBMET03299 | |
| 0.057 | 0.217 | 0.181 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.129 0.106 DBMET03295 0.12 0.117 DBMET03298 0.181 0.073 DBMET03299 | DBMET03299 | |
| 0.083 | 0.243 | 0.162 | Adenylate cyclase stimulant | 0.122 0.121 DBMET03294 0.162 0.045 DBMET03299 | DBMET03299 | |
| 0.031 | 0.191 | 0.145 | Calcium antagonist | 0.145 0.024 DBMET03299 | DBMET03299 | |
| 0.032 | 0.194 | 0.06 | Protease 3C (Human rhinovirus) inhibitor | 0.06 0.053 DBMET03298 | DBMET03298 | |
| 0.03 | 0.194 | 0.198 | MAO A inhibitor | 0.198 0.03 DBMET03299 | DBMET03299 | |
| 0.041 | 0.208 | 0.092 | Histamine H2 receptor antagonist | 0.092 0.044 DBMET03299 | DBMET03299 | |
| 0.152 | 0.319 | 0.193 | MAP kinase kinase 3 inhibitor | 0.193 0.144 DBMET03295 0.186 0.168 DBMET03297 | DBMET03295 | |
| 0.085 | 0.253 | 0.435 | Immunostimulant | 0.412 0.046 DBMET03293 0.215 0.112 DBMET03299 0.161 0.145 DBMET03300 0.435 0.04 DBMET03301 0.417 0.045 DBMET03296 | DBMET03301 | |
| 0.018 | 0.188 | 0.048 | 5 Hydroxytryptamine 2B agonist | 0.048 0.015 DBMET03299 | DBMET03299 | |
| 0.055 | 0.227 | 0.116 | Estrogen-related receptor beta agonist | 0.116 0.012 DBMET03299 | DBMET03299 | |
| 0.033 | 0.205 | 0.102 | Protein kinase B gamma inhibitor | 0.102 0.031 DBMET03299 | DBMET03299 | |
| 0.09 | 0.262 | 0.194 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.15 0.128 DBMET03295 0.194 0.081 DBMET03299 | DBMET03299 | |
| 0.015 | 0.188 | 0.028 | Toll-Like receptor 4 agonist | 0.027 0.017 DBMET03293 0.028 0.014 DBMET03301 0.027 0.017 DBMET03296 | DBMET03301 | |
| 0.063 | 0.238 | 0.21 | Protein kinase (CK1) gamma 1 inhibitor | 0.21 0.039 DBMET03299 | DBMET03299 | |
| 0.039 | 0.217 | 0.172 | Mediator release inhibitor | 0.112 0.056 DBMET03293 0.172 0.021 DBMET03301 | DBMET03301 | |
| 0.01 | 0.191 | 0.034 | Cholesterol ester transfer protein antagonist | 0.034 0.019 DBMET03299 | DBMET03299 | |
| 0.081 | 0.264 | 0.378 | Antiamyloidogenic | 0.257 0.068 DBMET03293 0.323 0.045 DBMET03299 0.215 0.089 DBMET03301 0.378 0.033 DBMET03296 | DBMET03296 | |
| 0.028 | 0.212 | 0.086 | Epoxide hydrolase inhibitor | 0.086 0.036 DBMET03299 | DBMET03299 | |
| 0.14 | 0.328 | 0.529 | Calcium channel activator | 0.529 0.004 DBMET03299 | DBMET03299 | |
| 0.046 | 0.235 | 0.092 | Phosphodiesterase 11A inhibitor | 0.092 0.04 DBMET03299 | DBMET03299 | |
| 0.046 | 0.235 | 0.092 | Phosphodiesterase XI inhibitor | 0.092 0.04 DBMET03299 | DBMET03299 | |
| 0.08 | 0.269 | 0.233 | Platelet antagonist | 0.207 0.096 DBMET03293 0.233 0.08 DBMET03294 0.154 0.141 DBMET03301 0.189 0.109 DBMET03296 0.211 0.093 DBMET03297 | DBMET03294 | |
| 0.027 | 0.217 | 0.101 | Potassium channel (ATP-sensitive) blocker | 0.101 0.015 DBMET03299 | DBMET03299 | |
| 0.131 | 0.322 | 0.348 | Apoptosis antagonist | 0.309 0.08 DBMET03293 0.348 0.057 DBMET03301 0.32 0.073 DBMET03296 0.207 0.17 DBMET03297 | DBMET03301 | |
| 0.058 | 0.253 | 0.151 | Cell adhesion inhibitor | 0.151 0.046 DBMET03293 0.1 0.089 DBMET03294 0.125 0.062 DBMET03301 0.142 0.051 DBMET03296 | DBMET03293 | |
| 0.053 | 0.249 | 0.37 | Toll-Like receptor 3 antagonist | 0.37 0.003 DBMET03299 0.084 0.083 DBMET03302 | DBMET03299 | |
| 0.053 | 0.25 | 0.207 | Protein kinase C nu inhibitor | 0.207 0.045 DBMET03299 | DBMET03299 | |
| 0.016 | 0.215 | 0.073 | Lysophosphatidic acid 3 receptor antagonist | 0.073 0.012 DBMET03299 | DBMET03299 | |
| 0.049 | 0.25 | 0.22 | Sodium channel blocker | 0.107 0.101 DBMET03298 0.22 0.026 DBMET03299 | DBMET03299 | |
| 0.02 | 0.221 | 0.086 | Sphingosine 1-phosphate receptor 3 antagonist | 0.086 0.013 DBMET03299 | DBMET03299 | |
| 0.04 | 0.243 | 0.084 | Cell adhesion molecule inhibitor | 0.084 0.048 DBMET03293 0.083 0.049 DBMET03296 | DBMET03293 | |
| 0.041 | 0.244 | 0.091 | Alpha 2c adrenoreceptor antagonist | 0.091 0.074 DBMET03299 | DBMET03299 | |
| 0.054 | 0.258 | 0.172 | Toll-Like receptor 2 antagonist | 0.172 0.038 DBMET03299 | DBMET03299 | |
| 0.044 | 0.252 | 0.109 | MAP kinase kinase 1 inhibitor | 0.109 0.047 DBMET03299 | DBMET03299 | |
| 0.042 | 0.252 | 0.206 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.132 0.091 DBMET03298 0.206 0.048 DBMET03299 | DBMET03299 | |
| 0.067 | 0.283 | 0.493 | Interleukin antagonist | 0.493 0.02 DBMET03299 | DBMET03299 | |
| 0.028 | 0.246 | 0.129 | Topoisomerase I inhibitor | 0.106 0.065 DBMET03293 0.129 0.05 DBMET03301 0.112 0.061 DBMET03296 | DBMET03301 | |
| 0.012 | 0.23 | 0.039 | Estrogen-related receptor gamma antagonist | 0.039 0.005 DBMET03299 | DBMET03299 | |
| 0.134 | 0.357 | 0.313 | 5 Hydroxytryptamine uptake stimulant | 0.245 0.086 DBMET03298 0.313 0.039 DBMET03299 | DBMET03299 | |
| 0.023 | 0.247 | 0.076 | Phospholipase D inhibitor | 0.076 0.041 DBMET03300 | DBMET03300 | |
| 0.094 | 0.32 | 0.245 | Calpain 2 inhibitor | 0.245 0.153 DBMET03299 | DBMET03299 | |
| 0.094 | 0.321 | 0.176 | Neurotensin receptor agonist | 0.14 0.13 DBMET03295 0.152 0.096 DBMET03299 0.176 0.055 DBMET03297 | DBMET03297 | |
| 0.043 | 0.273 | 0.102 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.102 0.101 DBMET03299 | DBMET03299 | |
| 0.091 | 0.326 | 0.423 | Superoxide dismutase inhibitor | 0.423 0.023 DBMET03299 0.278 0.059 DBMET03300 | DBMET03299 | |
| 0.033 | 0.268 | 0.084 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.058 DBMET03299 0.084 0.029 DBMET03297 | DBMET03297 | |
| 0.005 | 0.244 | 0.036 | Retinoid X receptor agonist | 0.036 0.025 DBMET03299 | DBMET03299 | |
| 0.03 | 0.27 | 0.117 | Protein kinase C delta inhibitor | 0.117 0.039 DBMET03299 | DBMET03299 | |
| 0.089 | 0.331 | 0.378 | Transcription factor NF kappa B inhibitor | 0.378 0.069 DBMET03293 0.21 0.159 DBMET03299 0.335 0.082 DBMET03301 0.303 0.092 DBMET03296 | DBMET03293 | |
| 0.019 | 0.265 | 0.093 | Acetylcholine nicotinic antagonist | 0.093 0.044 DBMET03299 | DBMET03299 | |
| 0.048 | 0.295 | 0.154 | Amyloid beta aggregation inhibitor | 0.154 0.105 DBMET03299 | DBMET03299 | |
| 0.005 | 0.252 | 0.05 | Kinesin-like protein 1 inhibitor | 0.05 0.016 DBMET03299 | DBMET03299 | |
| 0.005 | 0.252 | 0.05 | Kinesin antagonist | 0.05 0.016 DBMET03299 | DBMET03299 | |
| 0.044 | 0.292 | 0.229 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.229 0.057 DBMET03299 | DBMET03299 | |
| 0.043 | 0.293 | 0.092 | Nav1.4 sodium channel blocker | 0.092 0.089 DBMET03299 | DBMET03299 | |
| 0.065 | 0.315 | 0.25 | Hepatoprotectant | 0.25 0.043 DBMET03293 0.239 0.047 DBMET03301 0.249 0.044 DBMET03296 | DBMET03293 | |
| 0.035 | 0.287 | 0.094 | Protein kinase C gamma inhibitor | 0.094 0.088 DBMET03299 | DBMET03299 | |
| 0.012 | 0.267 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 DBMET03301 | DBMET03301 | |
| 0.04 | 0.295 | 0.137 | Protein kinase (CK1) gamma 2 inhibitor | 0.137 0.054 DBMET03299 | DBMET03299 | |
| 0.074 | 0.338 | 0.172 | Neurotrophic factor enhancer | 0.172 0.108 DBMET03299 | DBMET03299 | |
| 0.09 | 0.355 | 0.145 | Catenin beta inhibitor | 0.145 0.118 DBMET03299 | DBMET03299 | |
| 0.015 | 0.282 | 0.073 | Calcium channel T-type blocker | 0.073 0.026 DBMET03299 | DBMET03299 | |
| 0.043 | 0.314 | 0.104 | Transcription factor NF kappa B stimulant | 0.086 0.057 DBMET03293 0.104 0.035 DBMET03301 0.088 0.055 DBMET03296 | DBMET03301 | |
| 0.025 | 0.303 | 0.085 | Interferon agonist | 0.074 0.062 DBMET03299 0.085 0.045 DBMET03301 | DBMET03301 | |
| 0.005 | 0.285 | 0.086 | Glycine transporter inhibitor | 0.086 0.015 DBMET03299 | DBMET03299 | |
| 0.013 | 0.293 | 0.037 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.022 DBMET03299 | DBMET03299 | |
| 0.023 | 0.306 | 0.129 | Alcohol dehydrogenase inhibitor | 0.084 0.072 DBMET03295 0.116 0.037 DBMET03299 0.129 0.029 DBMET03297 | DBMET03297 | |
| 0.043 | 0.325 | 0.19 | Nav1.5 sodium channel blocker | 0.19 0.015 DBMET03299 | DBMET03299 | |
| 0.027 | 0.31 | 0.113 | Aminopeptidase B inhibitor | 0.113 0.057 DBMET03299 | DBMET03299 | |
| 0.013 | 0.297 | 0.048 | Potassium channel (Inward rectifier) blocker | 0.048 0.037 DBMET03299 | DBMET03299 | |
| 0.066 | 0.353 | 0.298 | Antioxidant | 0.293 0.064 DBMET03293 0.298 0.062 DBMET03301 0.283 0.068 DBMET03296 | DBMET03301 | |
| 0.01 | 0.297 | 0.144 | MAO B inhibitor | 0.144 0.039 DBMET03299 | DBMET03299 | |
| 0.025 | 0.314 | 0.065 | Interferon inducer | 0.059 0.057 DBMET03299 0.065 0.044 DBMET03301 | DBMET03301 | |
| 0.008 | 0.304 | 0.039 | GABA uptake inhibitor | 0.039 0.027 DBMET03299 | DBMET03299 | |
| 0.01 | 0.305 | 0.045 | Delayed rectifier potassium channel blocker | 0.045 0.016 DBMET03299 | DBMET03299 | |
| 0.033 | 0.33 | 0.126 | Ribosomal protein S6 kinase inhibitor | 0.126 0.084 DBMET03299 | DBMET03299 | |
| 0.052 | 0.353 | 0.202 | Nitric oxide antagonist | 0.186 0.073 DBMET03293 0.202 0.066 DBMET03301 0.168 0.083 DBMET03296 | DBMET03301 | |
| 0.052 | 0.356 | 0.165 | Sphingosine 1-phosphate receptor 4 antagonist | 0.165 0.022 DBMET03299 | DBMET03299 | |
| 0.083 | 0.388 | 0.441 | Cholesterol antagonist | 0.313 0.083 DBMET03293 0.267 0.113 DBMET03299 0.441 0.042 DBMET03301 0.285 0.101 DBMET03296 | DBMET03301 | |
| 0.059 | 0.37 | 0.256 | Tumour necrosis factor alpha release inhibitor | 0.24 0.079 DBMET03293 0.256 0.072 DBMET03301 0.237 0.081 DBMET03296 | DBMET03301 | |
| 0.094 | 0.406 | 0.263 | Insulysin inhibitor | 0.263 0.085 DBMET03299 0.198 0.159 DBMET03297 | DBMET03299 | |
| 0.022 | 0.335 | 0.081 | I kappa B kinase inhibitor | 0.081 0.059 DBMET03299 | DBMET03299 | |
| 0.028 | 0.344 | 0.136 | Protein kinase (CK1) gamma inhibitor | 0.136 0.076 DBMET03299 | DBMET03299 | |
| 0.014 | 0.331 | 0.082 | Sphingosine 1-phosphate receptor 4 agonist | 0.082 0.035 DBMET03299 | DBMET03299 | |
| 0.026 | 0.346 | 0.166 | Creatine kinase inhibitor | 0.166 0.018 DBMET03299 | DBMET03299 | |
| 0.114 | 0.44 | 0.356 | 5 Hydroxytryptamine 3E antagonist | 0.165 0.154 DBMET03298 0.356 0.003 DBMET03299 | DBMET03299 | |
| 0.039 | 0.368 | 0.156 | Protein kinase stimulant | 0.156 0.064 DBMET03299 | DBMET03299 | |
| 0.036 | 0.369 | 0.122 | Toll-Like receptor antagonist | 0.122 0.082 DBMET03299 | DBMET03299 | |
| 0.028 | 0.362 | 0.084 | Glutathione S-transferase inhibitor | 0.084 0.055 DBMET03299 | DBMET03299 | |
| 0.036 | 0.377 | 0.341 | Anesthetic general | 0.341 0.025 DBMET03299 | DBMET03299 | |
| 0.046 | 0.393 | 0.258 | Free radical scavenger | 0.256 0.066 DBMET03293 0.24 0.073 DBMET03301 0.258 0.065 DBMET03296 | DBMET03296 | |
| 0.04 | 0.393 | 0.149 | Glutamate (mGluR7) agonist | 0.149 0.012 DBMET03299 | DBMET03299 | |
| 0.039 | 0.396 | 0.141 | Cyclooxygenase 3 inhibitor | 0.141 0.056 DBMET03299 | DBMET03299 | |
| 0.024 | 0.387 | 0.203 | Sodium channel (voltage-gated) blocker | 0.203 0.028 DBMET03299 | DBMET03299 | |
| 0.082 | 0.447 | 0.234 | Histamine release inhibitor | 0.218 0.183 DBMET03293 0.234 0.168 DBMET03299 0.212 0.188 DBMET03302 0.203 0.199 DBMET03296 | DBMET03299 | |
| 0.025 | 0.391 | 0.078 | Glycine receptor agonist | 0.078 0.042 DBMET03299 | DBMET03299 | |
| 0.032 | 0.399 | 0.076 | MAP kinase kinase 7 inhibitor | 0.076 0.059 DBMET03299 | DBMET03299 | |
| 0.004 | 0.373 | 0.069 | Vascular adhesion protein 1 inhibitor | 0.069 0.006 DBMET03299 | DBMET03299 | |
| 0.005 | 0.38 | 0.039 | Sodium/glucose cotransporter inhibitor | 0.026 0.016 DBMET03299 0.039 0.007 DBMET03301 | DBMET03301 | |
| 0.005 | 0.385 | 0.041 | Retinoid X alpha receptor agonist | 0.041 0.019 DBMET03299 | DBMET03299 | |
| 0.033 | 0.413 | 0.148 | Toll-Like receptor 4 antagonist | 0.125 0.039 DBMET03293 0.148 0.022 DBMET03301 0.135 0.03 DBMET03296 | DBMET03301 | |
| 0.021 | 0.403 | 0.097 | Topoisomerase II inhibitor | 0.097 0.089 DBMET03296 | DBMET03296 | |
| 0.034 | 0.416 | 0.101 | DOPA decarboxylase inhibitor | 0.101 0.074 DBMET03299 | DBMET03299 | |
| 0.006 | 0.39 | 0.061 | Dopamine D5 agonist | 0.061 0.011 DBMET03299 | DBMET03299 | |
| 0.067 | 0.451 | 0.182 | Neuropeptide Y2 antagonist | 0.182 0.156 DBMET03299 | DBMET03299 | |
| 0.01 | 0.395 | 0.082 | Catalase inhibitor | 0.082 0.046 DBMET03299 | DBMET03299 | |
| 0.018 | 0.404 | 0.115 | Alkylator | 0.115 0.073 DBMET03299 0.11 0.078 DBMET03301 | DBMET03299 | |
| 0.032 | 0.419 | 0.118 | DNA polymerase I inhibitor | 0.118 0.07 DBMET03301 | DBMET03301 | |
| 0.008 | 0.397 | 0.078 | Neuronal nicotinic receptor antagonist | 0.078 0.038 DBMET03299 | DBMET03299 | |
| 0.043 | 0.434 | 0.114 | Interleukin 12 antagonist | 0.114 0.035 DBMET03299 | DBMET03299 | |
| 0.018 | 0.416 | 0.069 | Potassium channel (Tandem pore domain) blocker | 0.069 0.066 DBMET03299 | DBMET03299 | |
| 0.013 | 0.415 | 0.052 | Cytokine production stimulant | 0.052 0.025 DBMET03299 | DBMET03299 | |
| 0.012 | 0.418 | 0.075 | Inducible nitric-oxide synthase inhibitor | 0.075 0.07 DBMET03299 | DBMET03299 | |
| 0.011 | 0.42 | 0.102 | Glutamate decarboxylase inhibitor | 0.102 0.028 DBMET03299 | DBMET03299 | |
| 0.004 | 0.417 | 0.053 | Ornithine carbamoyltransferase inhibitor | 0.053 0.037 DBMET03299 | DBMET03299 | |
| 0.008 | 0.421 | 0.043 | Histamine H1 receptor agonist | 0.043 0.031 DBMET03299 | DBMET03299 | |
| 0.047 | 0.469 | 0.145 | DNA repair enzyme inhibitor | 0.127 0.06 DBMET03293 0.111 0.094 DBMET03299 0.145 0.036 DBMET03301 0.12 0.073 DBMET03296 | DBMET03301 | |
| 0.036 | 0.468 | 0.317 | Aldehyde oxidase inhibitor | 0.317 0.062 DBMET03299 | DBMET03299 | |
| 0.047 | 0.48 | 0.174 | ATPase inhibitor | 0.174 0.065 DBMET03299 | DBMET03299 | |
| 0.016 | 0.457 | 0.11 | Mucolytic | 0.11 0.065 DBMET03299 | DBMET03299 | |
| 0.003 | 0.446 | 0.044 | Glutamate (mGluR group II) antagonist | 0.044 0.021 DBMET03299 | DBMET03299 | |
| 0.017 | 0.461 | 0.115 | Histamine N-methyltransferase inhibitor | 0.115 0.033 DBMET03299 | DBMET03299 | |
| 0.004 | 0.457 | 0.022 | Retinoid X beta receptor antagonist | 0.022 0.011 DBMET03299 | DBMET03299 | |
| 0.012 | 0.465 | 0.088 | Expectorant | 0.088 0.084 DBMET03299 | DBMET03299 | |
| 0.01 | 0.468 | 0.052 | Protein 50S ribosomal subunit inhibitor | 0.05 0.04 DBMET03293 0.052 0.038 DBMET03301 0.049 0.041 DBMET03296 | DBMET03301 | |
| 0.019 | 0.477 | 0.049 | Parathyroid hormone antagonist | 0.049 0.022 DBMET03299 | DBMET03299 | |
| 0.003 | 0.468 | 0.03 | Glutamate (mGluR2) antagonist | 0.03 0.02 DBMET03299 | DBMET03299 | |
| 0.034 | 0.505 | 0.171 | DNA methylase inhibitor | 0.149 0.118 DBMET03299 0.171 0.1 DBMET03296 | DBMET03296 | |
| 0.073 | 0.551 | 0.356 | Apoptosis agonist | 0.332 0.15 DBMET03293 0.339 0.146 DBMET03301 0.356 0.136 DBMET03296 | DBMET03296 | |
| 0.024 | 0.502 | 0.239 | Antibacterial (Helicobacter pylori) | 0.239 0.014 DBMET03299 | DBMET03299 | |
| 0.009 | 0.49 | 0.107 | Phenylalanine 4-hydroxylase inhibitor | 0.107 0.023 DBMET03299 | DBMET03299 | |
| 0.009 | 0.493 | 0.085 | Histidine decarboxylase inhibitor | 0.085 0.039 DBMET03299 | DBMET03299 | |
| 0.003 | 0.492 | 0.055 | Diamine oxidase inhibitor | 0.055 0.012 DBMET03299 | DBMET03299 | |
| 0.031 | 0.519 | 0.074 | Calcium channel P-type blocker | 0.074 0.021 DBMET03299 | DBMET03299 | |
| 0.016 | 0.506 | 0.139 | Myeloperoxidase inhibitor | 0.139 0.013 DBMET03299 | DBMET03299 | |
| 0.033 | 0.529 | 0.167 | Platelet adhesion inhibitor | 0.167 0.09 DBMET03293 0.15 0.105 DBMET03301 0.153 0.103 DBMET03296 | DBMET03293 | |
| 0.028 | 0.529 | 0.149 | Carbonic anhydrase XV inhibitor | 0.149 0.031 DBMET03299 | DBMET03299 | |
| 0.025 | 0.527 | 0.098 | Granulocyte macrophage colony stimulating factor agonist | 0.098 0.038 DBMET03299 | DBMET03299 | |
| 0.003 | 0.505 | 0.035 | Free fatty acid receptor 1 antagonist | 0.035 0.021 DBMET03299 | DBMET03299 | |
| 0.007 | 0.51 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.027 DBMET03299 | DBMET03299 | |
| 0.018 | 0.522 | 0.079 | Glutamate dehydrogenase inhibitor | 0.079 0.046 DBMET03299 | DBMET03299 | |
| 0.009 | 0.515 | 0.066 | Squalene epoxidase inhibitor | 0.066 0.016 DBMET03299 | DBMET03299 | |
| 0.014 | 0.524 | 0.091 | Ornithine decarboxylase inhibitor | 0.091 0.055 DBMET03299 | DBMET03299 | |
| 0.009 | 0.521 | 0.039 | Retinoid X alpha receptor antagonist | 0.039 0.016 DBMET03299 | DBMET03299 | |
| 0.037 | 0.553 | 0.169 | Phospholipase C inhibitor | 0.169 0.074 DBMET03299 | DBMET03299 | |
| 0.018 | 0.535 | 0.141 | GABA C receptor rho-1 antagonist | 0.141 0.025 DBMET03299 | DBMET03299 | |
| 0.006 | 0.525 | 0.072 | Carbamoyl phosphate synthetase inhibitor | 0.072 0.033 DBMET03299 | DBMET03299 | |
| 0.009 | 0.535 | 0.045 | Retinoid X receptor antagonist | 0.045 0.017 DBMET03299 | DBMET03299 | |
| 0.075 | 0.602 | 0.46 | Antiinflammatory | 0.439 0.116 DBMET03293 0.42 0.127 DBMET03301 0.46 0.105 DBMET03296 | DBMET03296 | |
| 0.005 | 0.532 | 0.054 | 5 Hydroxytryptamine 6 antagonist | 0.054 0.043 DBMET03299 | DBMET03299 | |
| 0.002 | 0.535 | 0.022 | Glutamate (mGluR1a) agonist | 0.022 0.016 DBMET03299 | DBMET03299 | |
| 0.009 | 0.542 | 0.107 | Glycogen synthase kinase-3 alpha inhibitor | 0.107 0.096 DBMET03299 | DBMET03299 | |
| 0.06 | 0.6 | 0.19 | Caspase 3 stimulant | 0.19 0.185 DBMET03301 | DBMET03301 | |
| 0.077 | 0.618 | 0.147 | Heat shock protein 70 antagonist | 0.147 0.052 DBMET03299 | DBMET03299 | |
| 0.006 | 0.549 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.112 0.022 DBMET03299 | DBMET03299 | |
| 0.013 | 0.56 | 0.219 | GABA C receptor antagonist | 0.219 0.009 DBMET03299 | DBMET03299 | |
| 0.016 | 0.574 | 0.092 | Keratolytic | 0.092 0.036 DBMET03299 | DBMET03299 | |
| 0.021 | 0.581 | 0.111 | Aldehyde dehydrogenase inhibitor | 0.111 0.081 DBMET03299 | DBMET03299 | |
| 0.004 | 0.568 | 0.04 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.04 0.017 DBMET03299 | DBMET03299 | |
| 0.029 | 0.602 | 0.189 | Transcription factor STAT3 inhibitor | 0.189 0.149 DBMET03299 | DBMET03299 | |
| 0.03 | 0.607 | 0.235 | DNA damaging | 0.235 0.089 DBMET03299 | DBMET03299 | |
| 0.006 | 0.585 | 0.057 | Cholesterol esterase inhibitor | 0.057 0.02 DBMET03299 | DBMET03299 | |
| 0.017 | 0.598 | 0.099 | Carbonic anhydrase VI inhibitor | 0.099 0.04 DBMET03299 | DBMET03299 | |
| 0.011 | 0.594 | 0.043 | Glutamate (mGluR4) antagonist | 0.043 0.032 DBMET03299 | DBMET03299 | |
| 0.03 | 0.615 | 0.148 | 3C-like protease (Human coronavirus) inhibitor | 0.148 0.104 DBMET03299 | DBMET03299 | |
| 0.007 | 0.594 | 0.028 | Glucosylceramidase stimulant | 0.028 0.017 DBMET03299 | DBMET03299 | |
| 0.004 | 0.592 | 0.077 | Nav1.7 sodium channel blocker | 0.077 0.036 DBMET03299 | DBMET03299 | |
| 0.015 | 0.611 | 0.139 | Alpha-N-acetylglucosaminidase inhibitor | 0.139 0.062 DBMET03299 | DBMET03299 | |
| 0.004 | 0.603 | 0.055 | TRPA1 antagonist | 0.055 0.05 DBMET03299 | DBMET03299 | |
| 0.02 | 0.622 | 0.171 | DNA synthesis inhibitor | 0.171 0.167 DBMET03301 | DBMET03301 | |
| 0.005 | 0.612 | 0.041 | Mannosidase inhibitor | 0.041 0.038 DBMET03299 | DBMET03299 | |
| 0.015 | 0.625 | 0.095 | Anabolic | 0.095 0.07 DBMET03299 | DBMET03299 | |
| 0.023 | 0.634 | 0.106 | Photosensitizer | 0.106 0.077 DBMET03299 | DBMET03299 | |
| 0.014 | 0.627 | 0.173 | I kappa B kinase epsilon inhibitor | 0.173 0.096 DBMET03299 | DBMET03299 | |
| 0.003 | 0.618 | 0.023 | Glutaminyl-peptide cyclotransferase inhibitor | 0.023 0.012 DBMET03299 | DBMET03299 | |
| 0.011 | 0.627 | 0.219 | Beta amyloid protein antagonist | 0.219 0.012 DBMET03299 | DBMET03299 | |
| 0.035 | 0.656 | 0.145 | NOS3 expression enhancer | 0.145 0.077 DBMET03301 | DBMET03301 | |
| 0.009 | 0.634 | 0.088 | Macrophage migration inhibitory factor inhibitor | 0.088 0.043 DBMET03299 | DBMET03299 | |
| 0.015 | 0.641 | 0.1 | Exportin-1 inhibitor | 0.1 0.009 DBMET03299 | DBMET03299 | |
| 0.008 | 0.641 | 0.087 | GABA aminotransferase inhibitor | 0.087 0.038 DBMET03299 | DBMET03299 | |
| 0.007 | 0.642 | 0.128 | LIM domain kinase 1 inhibitor | 0.128 0.124 DBMET03299 | DBMET03299 | |
| 0.008 | 0.647 | 0.036 | Glutamate (mGluR8) agonist | 0.036 0.03 DBMET03299 | DBMET03299 | |
| 0.029 | 0.676 | 0.145 | CF transmembrane conductance regulator agonist | 0.145 0.086 DBMET03299 | DBMET03299 | |
| 0.003 | 0.651 | 0.049 | Nicotinic receptor alpha7 subunit antagonist | 0.049 0.046 DBMET03299 | DBMET03299 | |
| 0.01 | 0.66 | 0.23 | GABA C receptor agonist | 0.23 0.016 DBMET03299 | DBMET03299 | |
| 0.017 | 0.667 | 0.115 | Carbonic anhydrase III inhibitor | 0.115 0.048 DBMET03299 | DBMET03299 | |
| 0.001 | 0.651 | 0.028 | Uridine phosphorylase inhibitor | 0.028 0.019 DBMET03299 | DBMET03299 | |
| 0.003 | 0.655 | 0.067 | Phosphofructokinase-1 inhibitor | 0.067 0.05 DBMET03299 | DBMET03299 | |
| 0.009 | 0.661 | 0.036 | Vanilloid 3 antagonist | 0.036 0.035 DBMET03299 | DBMET03299 | |
| 0.004 | 0.66 | 0.17 | Alcohol oxidase inhibitor | 0.17 0.008 DBMET03299 | DBMET03299 | |
| 0.016 | 0.678 | 0.197 | Succinate dehydrogenase inhibitor | 0.197 0.051 DBMET03299 | DBMET03299 | |
| 0.013 | 0.676 | 0.11 | Cathepsin H inhibitor | 0.11 0.089 DBMET03299 | DBMET03299 | |
| 0.01 | 0.675 | 0.112 | Toll-Like receptor 9 antagonist | 0.112 0.095 DBMET03299 | DBMET03299 | |
| 0.009 | 0.683 | 0.093 | GABA B receptor agonist | 0.093 0.022 DBMET03299 | DBMET03299 | |
| 0.005 | 0.682 | 0.057 | Aconitate hydratase inhibitor | 0.057 0.029 DBMET03299 | DBMET03299 | |
| 0.007 | 0.687 | 0.063 | Potassium channel intermediate-conductance Ca-activated blocker | 0.063 0.036 DBMET03299 | DBMET03299 | |
| 0.015 | 0.698 | 0.112 | Triose-phosphate isomerase inhibitor | 0.112 0.037 DBMET03299 | DBMET03299 | |
| 0.003 | 0.689 | 0.059 | Acyl-CoA dehydrogenase inhibitor | 0.059 0.034 DBMET03299 | DBMET03299 | |
| 0.013 | 0.7 | 0.066 | Glutamate (mGluR6) antagonist | 0.066 0.049 DBMET03299 | DBMET03299 | |
| 0.031 | 0.722 | 0.111 | Glutamate release inhibitor | 0.111 0.029 DBMET03299 | DBMET03299 | |
| 0.01 | 0.711 | 0.147 | Dual specificity phosphatase 3 inhibitor | 0.147 0.099 DBMET03300 | DBMET03300 | |
| 0.043 | 0.747 | 0.141 | Ca2+-transporting ATPase inhibitor | 0.141 0.069 DBMET03299 | DBMET03299 | |
| 0.056 | 0.76 | 0.245 | Nitric-oxide synthase stimulant | 0.245 0.036 DBMET03299 | DBMET03299 | |
| 0.012 | 0.72 | 0.143 | Dual specificity phosphatase inhibitor | 0.143 0.102 DBMET03300 | DBMET03300 | |
| 0.002 | 0.711 | 0.051 | Carbonic anhydrase VB inhibitor | 0.051 0.044 DBMET03299 | DBMET03299 | |
| 0.042 | 0.753 | 0.349 | Caspase 9 stimulant | 0.349 0.146 DBMET03299 | DBMET03299 | |
| 0.068 | 0.782 | 0.39 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.39 0.11 DBMET03299 | DBMET03299 | |
| 0.017 | 0.739 | 0.227 | Peroxidase inhibitor | 0.227 0.052 DBMET03299 | DBMET03299 | |
| 0.009 | 0.736 | 0.114 | UDP-glucose 4-epimerase inhibitor | 0.114 0.047 DBMET03299 | DBMET03299 | |
| 0.007 | 0.741 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.035 DBMET03299 | DBMET03299 | |
| 0.014 | 0.752 | 0.095 | NADH dehydrogenase inhibitor | 0.095 0.049 DBMET03299 | DBMET03299 | |
| 0.005 | 0.745 | 0.079 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.079 0.038 DBMET03299 | DBMET03299 | |
| 0.007 | 0.747 | 0.044 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.041 DBMET03299 | DBMET03299 | |
| 0.016 | 0.76 | 0.152 | GABA C receptor rho-2 antagonist | 0.152 0.071 DBMET03299 | DBMET03299 | |
| 0.011 | 0.757 | 0.248 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.248 0.043 DBMET03299 | DBMET03299 | |
| 0.021 | 0.767 | 0.126 | Adenylate kinase inhibitor | 0.126 0.039 DBMET03299 | DBMET03299 | |
| 0.004 | 0.751 | 0.086 | Porphobilinogen synthase inhibitor | 0.086 0.043 DBMET03299 | DBMET03299 | |
| 0.007 | 0.775 | 0.15 | Arachidonic acid antagonist | 0.15 0.089 DBMET03299 | DBMET03299 | |
| 0.005 | 0.777 | 0.054 | Dopamine beta hydroxylase inhibitor | 0.054 0.024 DBMET03299 | DBMET03299 | |
| 0.007 | 0.781 | 0.109 | 5 Hydroxytryptamine 3A agonist | 0.109 0.066 DBMET03299 | DBMET03299 | |
| 0.005 | 0.81 | 0.157 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.157 0.134 DBMET03299 | DBMET03299 | |
| 0.006 | 0.817 | 0.183 | Mannose-6-phosphate isomerase inhibitor | 0.183 0.04 DBMET03299 | DBMET03299 | |
| 0.023 | 0.836 | 0.38 | GABA C receptor rho-3 antagonist | 0.38 0.071 DBMET03299 | DBMET03299 | |
| 0.002 | 0.819 | 0.053 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.053 0.044 DBMET03299 | DBMET03299 | |
| 0.008 | 0.828 | 0.413 | Antibacterial | 0.297 0.138 DBMET03293 0.289 0.144 DBMET03301 0.413 0.071 DBMET03296 | DBMET03296 | |
| 0.008 | 0.837 | 0.105 | Electrolyte absorption antagonist | 0.105 0.051 DBMET03299 | DBMET03299 | |
| 0.004 | 0.833 | 0.137 | CYP2A6 inhibitor | 0.137 0.02 DBMET03299 | DBMET03299 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |